169 related articles for article (PubMed ID: 32064037)
1. Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas.
Nakashima C; Yamamoto K; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Kawahara I; Nishiguchi Y; Mori T; Kondoh M; Luo Y; Kirita T; Kuniyasu H
Oncotarget; 2020 Jan; 11(4):309-321. PubMed ID: 32064037
[TBL] [Abstract][Full Text] [Related]
2. Role of
Fujiwara-Tani R; Fujii K; Mori S; Kishi S; Sasaki T; Ohmori H; Nakashima C; Kawahara I; Nishiguchi Y; Mori T; Sho M; Kondoh M; Luo Y; Kuniyasu H
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481659
[TBL] [Abstract][Full Text] [Related]
3. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
Fujiwara-Tani R; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Kondoh M; Kuniyasu H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982569
[TBL] [Abstract][Full Text] [Related]
4. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
5. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
[TBL] [Abstract][Full Text] [Related]
6. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
Gao Z; Xu X; McClane B; Zeng Q; Litkouhi B; Welch WR; Berkowitz RS; Mok SC; Garner EI
Clin Cancer Res; 2011 Mar; 17(5):1065-74. PubMed ID: 21123456
[TBL] [Abstract][Full Text] [Related]
7. Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Owari T; Sasaki T; Fujii K; Fujiwara-Tani R; Kishi S; Mori S; Mori T; Goto K; Kawahara I; Nakai Y; Miyake M; Luo Y; Tanaka N; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172177
[TBL] [Abstract][Full Text] [Related]
8. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
Gabig TG; Waltzer WC; Whyard T; Romanov V
Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
[TBL] [Abstract][Full Text] [Related]
9. The significance of Hippo pathway protein expression in oral squamous cell carcinoma.
Amano Y; Matsubara D; Kihara A; Yoshimoto T; Fukushima N; Nishino H; Mori Y; Niki T
Front Med (Lausanne); 2024; 11():1247625. PubMed ID: 38444414
[TBL] [Abstract][Full Text] [Related]
10. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
11. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.
Kominsky SL; Vali M; Korz D; Gabig TG; Weitzman SA; Argani P; Sukumar S
Am J Pathol; 2004 May; 164(5):1627-33. PubMed ID: 15111309
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
[TBL] [Abstract][Full Text] [Related]
13. Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.
Hashimoto Y; Yagi K; Kondoh M
Pflugers Arch; 2017 Jan; 469(1):45-53. PubMed ID: 27629072
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
[TBL] [Abstract][Full Text] [Related]
15. Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
Walther W; Petkov S; Kuvardina ON; Aumann J; Kobelt D; Fichtner I; Lemm M; Piontek J; Blasig IE; Stein U; Schlag PM
Gene Ther; 2012 May; 19(5):494-503. PubMed ID: 21975465
[TBL] [Abstract][Full Text] [Related]
16. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
[TBL] [Abstract][Full Text] [Related]
17. Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy.
Bang C; Park MG; Cho IK; Lee DE; Kim GL; Jang EH; Shim MK; Yoon HY; Lee S; Kim JH
Biomater Res; 2023 May; 27(1):53. PubMed ID: 37237291
[TBL] [Abstract][Full Text] [Related]
18. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
Michl P; Buchholz M; Rolke M; Kunsch S; Löhr M; McClane B; Tsukita S; Leder G; Adler G; Gress TM
Gastroenterology; 2001 Sep; 121(3):678-84. PubMed ID: 11522752
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
